{"blog": [], "keywords": [{"value": "Diabetes", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Insulin", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Eli Lilly and Company", "name": "organizations", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/02/29/opinion/for-some-diabetics-a-struggle-to-pay-for-insulin.html", "document_type": "article", "byline": [], "type_of_material": "Letter", "multimedia": [], "section_name": "Opinion", "word_count": "470", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The drug company Eli Lilly and an organization that helps diabetics discuss rising treatment costs.", "pub_date": "2016-02-29T00:00:00Z", "news_desk": "Letters", "headline": {"kicker": "Letters", "print_headline": "For Some Diabetics, a Struggle to Pay for Insulin", "main": "For Some Diabetics, a Struggle to Pay for Insulin", "content_kicker": "Letters"}, "print_page": "24", "snippet": "The drug company Eli Lilly and an organization that helps diabetics discuss rising treatment costs.", "_id": "56d3ff7638f0d86ef22e18be", "slideshow_credits": null, "abstract": null}